Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial.

Crockett SD, Barry EL, Mott LA, Ahnen DJ, Robertson DJ, Anderson JC, Wallace K, Burke CA, Bresalier RS, Figueiredo JC, Snover DC, Baron JA.

Gut. 2018 Mar 1. pii: gutjnl-2017-315242. doi: 10.1136/gutjnl-2017-315242. [Epub ahead of print]

PMID:
29496722
2.

Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.

Anderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ.

Gastroenterology. 2017 Jun;152(8):1933-1943.e5. doi: 10.1053/j.gastro.2017.02.010. Epub 2017 Feb 20.

PMID:
28219690
3.

Lifestyle and Other Factors Explain One-Half of the Variability in the Serum 25-Hydroxyvitamin D Response to Cholecalciferol Supplementation in Healthy Adults.

Rees JR, Mott LA, Barry EL, Baron JA, Bostick RM, Figueiredo JC, Bresalier RS, Robertson DJ, Peacock JL.

J Nutr. 2016 Nov;146(11):2312-2324. Epub 2016 Sep 28.

4.

Randomized controlled trials: who fails run-in?

Rees JR, Mott LA, Barry EL, Baron JA, Figueiredo JC, Robertson DJ, Bresalier RS, Peacock JL.

Trials. 2016 Jul 29;17:374. doi: 10.1186/s13063-016-1451-9.

5.

Association between adenoma location and risk of recurrence.

Pohl H, Robertson DJ, Mott LA, Ahnen DJ, Burke CA, Barry EL, Bresalier RS, Figueiredo JC, Shaukat A, Sandler RS, Baron JA.

Gastrointest Endosc. 2016 Oct;84(4):709-16. doi: 10.1016/j.gie.2016.02.048. Epub 2016 Mar 11.

6.

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, Beck GJ, Bresalier RS, Burke CA, Church TR, Cruz-Correa M, Figueiredo JC, Goodman M, Kim AS, Robertson DJ, Rothstein R, Shaukat A, Seabrook ME, Summers RW.

N Engl J Med. 2015 Oct 15;373(16):1519-30. doi: 10.1056/NEJMoa1500409.

7.

Calcium supplementation increases blood creatinine concentration in a randomized controlled trial.

Barry EL, Mott LA, Melamed ML, Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA.

PLoS One. 2014 Oct 15;9(10):e108094. doi: 10.1371/journal.pone.0108094. eCollection 2014.

8.

C-reactive protein and risk of colorectal adenomas or serrated polyps: a prospective study.

Crockett SD, Mott LA, Barry EL, Figueiredo JC, Burke CA, Baxter GJ, Sandler RS, Baron JA.

Cancer Prev Res (Phila). 2014 Nov;7(11):1122-7. doi: 10.1158/1940-6207.CAPR-14-0167. Epub 2014 Aug 21.

9.

Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.

Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA.

J Clin Endocrinol Metab. 2014 Oct;99(10):E2133-7. doi: 10.1210/jc.2014-1389. Epub 2014 Jul 29.

10.

Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial.

Rees JR, Hendricks K, Barry EL, Peacock JL, Mott LA, Sandler RS, Bresalier RS, Goodman M, Bostick RM, Baron JA.

Clin Infect Dis. 2013 Nov;57(10):1384-92. doi: 10.1093/cid/cit549. Epub 2013 Sep 6.

11.

Constipation and a low-fiber diet are not associated with diverticulosis.

Peery AF, Sandler RS, Ahnen DJ, Galanko JA, Holm AN, Shaukat A, Mott LA, Barry EL, Fried DA, Baron JA.

Clin Gastroenterol Hepatol. 2013 Dec;11(12):1622-7. doi: 10.1016/j.cgh.2013.06.033. Epub 2013 Jul 23.

12.

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.

Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM.

Cancer Causes Control. 2013 Jan;24(1):47-54. doi: 10.1007/s10552-012-0088-6. Epub 2012 Oct 19.

13.

Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.

Barry EL, Mott LA, Sandler RS, Ahnen DJ, Baron JA.

Cancer Prev Res (Phila). 2011 Dec;4(12):2072-82. doi: 10.1158/1940-6207.CAPR-11-0300. Epub 2011 Sep 19.

14.

Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials.

Figueiredo JC, Mott LA, Giovannucci E, Wu K, Cole B, Grainge MJ, Logan RF, Baron JA.

Int J Cancer. 2011 Jul 1;129(1):192-203. doi: 10.1002/ijc.25872. Epub 2011 Apr 1.

15.

Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation.

Levine AJ, Grau MV, Mott LA, Ueland PM, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2541-8. doi: 10.1158/1055-9965.EPI-10-0536. Epub 2010 Sep 14.

16.

Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics.

Robertson DJ, Burke CA, Welch HG, Haile RW, Sandler RS, Greenberg ER, Ahnen DJ, Bresalier RS, Rothstein RI, Cole B, Mott LA, Baron JA.

Ann Intern Med. 2009 Jul 21;151(2):103-9.

17.

Gastrin, Helicobacter pylori, and colorectal adenomas.

Robertson DJ, Sandler RS, Ahnen DJ, Greenberg ER, Mott LA, Cole BF, Baron JA.

Clin Gastroenterol Hepatol. 2009 Feb;7(2):163-7. doi: 10.1016/j.cgh.2008.09.006. Epub 2008 Sep 20.

PMID:
18929688
18.

Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study.

Karagas MR, Stukel TA, Umland V, Tsoukas MM, Mott LA, Sorensen HT, Jensen AO, Nelson HH, Spencer SK, Perry AE, Stern RS.

J Invest Dermatol. 2007 Dec;127(12):2901-3. Epub 2007 Jun 28. No abstract available.

19.

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER; Polyp Prevention Study Group.

JAMA. 2007 Jun 6;297(21):2351-9.

PMID:
17551129
20.

Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage.

Karagas MR, Zens MS, Nelson HH, Mabuchi K, Perry AE, Stukel TA, Mott LA, Andrew AS, Applebaum KM, Linet M.

Am J Epidemiol. 2007 Mar 15;165(6):719-26. Epub 2007 Jan 4.

PMID:
17204514
21.

Cognitive-behavioral management of chemotherapy-related cognitive change.

Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Mott LA.

Psychooncology. 2007 Aug;16(8):772-7.

22.

Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).

Kim S, Baron JA, Mott LA, Burke CA, Church TR, McKeown-Eyssen GE, Cole BF, Haile RW, Sandler RS.

Cancer Causes Control. 2006 Dec;17(10):1299-304.

PMID:
17111262
23.

Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.

Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M.

J Natl Cancer Inst. 2006 Mar 15;98(6):389-95.

PMID:
16537831
24.

Histamine receptor antagonists and incident colorectal adenomas.

Robertson DJ, Burke CA, Schwender BJ, Wargovich MJ, Greenberg ER, Sandler RS, Ahnen DJ, Rothstein R, Mott LA, Baron JA.

Aliment Pharmacol Ther. 2005 Jul 15;22(2):123-8.

25.

Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy.

Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Titus-Ernstoff L, Skalla K, Bakitas M, Silberfarb PM.

J Clin Oncol. 2005 Jul 1;23(19):4399-405.

26.

Reported use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors was not associated with reduced recurrence of colorectal adenomas.

Wei JT, Mott LA, Baron JA, Sandler RS; Polyp Prevention Study Group.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1026-7.

27.

Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.

Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT.

Cancer Lett. 2005 Feb 28;219(1):63-9.

PMID:
15694665
28.

Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.

Barth RJ Jr, Gibson GR, Carney PA, Mott LA, Becher RD, Poplack SP.

AJR Am J Roentgenol. 2005 Jan;184(1):324-9.

PMID:
15615996
29.

Occupation and bladder cancer risk in a population-based case-control study in New Hampshire.

Colt JS, Baris D, Stewart P, Schned AR, Heaney JA, Mott LA, Silverman D, Karagas M.

Cancer Causes Control. 2004 Oct;15(8):759-69.

PMID:
15456989
30.

Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.

Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A.

Cancer Causes Control. 2004 Jun;15(5):465-72.

PMID:
15286466
31.

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.

Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA.

Psychooncology. 2003 Sep;12(6):612-9.

PMID:
12923801
32.

A randomized trial of aspirin to prevent colorectal adenomas.

Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU.

N Engl J Med. 2003 Mar 6;348(10):891-9.

33.

Viewing tobacco use in movies: does it shape attitudes that mediate adolescent smoking?

Sargent JD, Dalton MA, Beach ML, Mott LA, Tickle JJ, Ahrens MB, Heatherton TF.

Am J Prev Med. 2002 Apr;22(3):137-45.

PMID:
11897456
34.

A pediatric, practice-based, randomized trial of drinking and smoking prevention and bicycle helmet, gun, and seatbelt safety promotion.

Stevens MM, Olson AL, Gaffney CA, Tosteson TD, Mott LA, Starr P.

Pediatrics. 2002 Mar;109(3):490-7.

PMID:
11875146
35.

Relation between parental restrictions on movies and adolescent use of tobacco and alcohol.

Dalton MA, Ahrens MB, Sargent JD, Mott LA, Beach ML, Tickle JJ, Heatherton TF.

Eff Clin Pract. 2002 Jan-Feb;5(1):1-10.

PMID:
11874190
36.

Use of tanning devices and risk of basal cell and squamous cell skin cancers.

Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA.

J Natl Cancer Inst. 2002 Feb 6;94(3):224-6.

PMID:
11830612
37.

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM.

J Clin Oncol. 2002 Jan 15;20(2):485-93.

PMID:
11786578
38.
39.

Effect of seeing tobacco use in films on trying smoking among adolescents: cross sectional study.

Sargent JD, Beach ML, Dalton MA, Mott LA, Tickle JJ, Ahrens MB, Heatherton TF.

BMJ. 2001 Dec 15;323(7326):1394-7.

40.

A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins.

Gibson GR, Lesnikoski BA, Yoo J, Mott LA, Cady B, Barth RJ Jr.

Ann Surg Oncol. 2001 Oct;8(9):693-704.

PMID:
11597009
41.

Non-melanoma skin cancers and glucocorticoid therapy.

Karagas MR, Cushing GL Jr, Greenberg ER, Mott LA, Spencer SK, Nierenberg DW.

Br J Cancer. 2001 Sep 1;85(5):683-6.

42.

Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer.

Nelson HH, Kelsey KT, Bronson MH, Mott LA, Karagas MR.

Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):809-10. No abstract available.

43.

Children and guns in a well child cohort.

Stevens MM, Gaffney CA, Tosteson TD, Mott LA, Olson A, Ahrens MB, Konings EK.

Prev Med. 2001 Mar;32(3):201-6.

PMID:
11277675
44.
45.

Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group.

Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER.

Arch Dermatol. 2000 Aug;136(8):1007-11.

PMID:
10926736
46.

Colorectal hyperplastic polyps and risk of recurrence of adenomas and hyperplastic polyps. Polyps Prevention Study.

Bensen SP, Cole BF, Mott LA, Baron JA, Sandler RS, Haile R.

Lancet. 1999 Nov 27;354(9193):1873-4.

PMID:
10584726
47.

Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group.

Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA.

Int J Cancer. 1999 May 17;81(4):555-9.

48.

The colonoscopic miss rate and true one-year recurrence of colorectal neoplastic polyps. Polyp Prevention Study Group.

Bensen S, Mott LA, Dain B, Rothstein R, Baron J.

Am J Gastroenterol. 1999 Jan;94(1):194-9.

PMID:
9934755
49.

Prevalence of mood disorders and utility of the PRIME-MD in patients undergoing radiation therapy.

Leopold KA, Ahles TA, Walch S, Amdur RJ, Mott LA, Wiegand-Packard L, Oxman TE.

Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1105-12.

PMID:
9869236
50.

Dietary and supplemental calcium and the recurrence of colorectal adenomas.

Hyman J, Baron JA, Dain BJ, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER.

Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):291-5.

Supplemental Content

Support Center